Alcohol-Related Liver Disease Including New Developments
Copyright © 2022 Elsevier Inc. All rights reserved..
The prevalence of alcohol consumption, alcohol use disorder (AUD), and alcohol-related liver disease (ALD) has exponentially increased over the last several years and rates continue to increase. Significant alcohol use can cause progression from steatosis in the liver to inflammation, fibrosis, and eventually cirrhosis. Additional risk factors for the progression of ALD disease include gender, race, and genetic predisposition. As such, it is essential for clinicians to understand and implement screening tools for early diagnosis of both AUD and ALD and be aware of emerging novel treatment options.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Clinics in liver disease - 27(2023), 1 vom: 18. Feb., Seite 157-172 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Patel, Parita Virendra [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Alcohol use disorder |
|---|
| Anmerkungen: |
Date Completed 22.11.2022 Date Revised 22.04.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cld.2022.08.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349136882 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349136882 | ||
| 003 | DE-627 | ||
| 005 | 20231226041915.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cld.2022.08.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1163.xml |
| 035 | |a (DE-627)NLM349136882 | ||
| 035 | |a (NLM)36400463 | ||
| 035 | |a (PII)S1089-3261(22)00069-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Patel, Parita Virendra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Alcohol-Related Liver Disease Including New Developments |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.11.2022 | ||
| 500 | |a Date Revised 22.04.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
| 520 | |a The prevalence of alcohol consumption, alcohol use disorder (AUD), and alcohol-related liver disease (ALD) has exponentially increased over the last several years and rates continue to increase. Significant alcohol use can cause progression from steatosis in the liver to inflammation, fibrosis, and eventually cirrhosis. Additional risk factors for the progression of ALD disease include gender, race, and genetic predisposition. As such, it is essential for clinicians to understand and implement screening tools for early diagnosis of both AUD and ALD and be aware of emerging novel treatment options | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Alcohol use disorder | |
| 650 | 4 | |a Alcohol-related liver disease | |
| 650 | 4 | |a Early transplantation | |
| 700 | 1 | |a Flamm, Steven L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinics in liver disease |d 1997 |g 27(2023), 1 vom: 18. Feb., Seite 157-172 |w (DE-627)NLM096493259 |x 1557-8224 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2023 |g number:1 |g day:18 |g month:02 |g pages:157-172 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cld.2022.08.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2023 |e 1 |b 18 |c 02 |h 157-172 | ||